{
    "2018-09-21": [
        [
            {
                "time": "2023-09-21",
                "original_text": "复星医药：子公司实体瘤治疗新药临床试验申请获受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "实体瘤",
                        "新药",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-09-21",
                "original_text": "全球资金流向监测：大幅流入美国，新兴依然流出但压力减轻",
                "features": {
                    "keywords": [
                        "全球资金流向",
                        "美国",
                        "新兴市场",
                        "资金流出",
                        "压力减轻"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-21",
                "original_text": "复星医药：带量采购政策有利于将质高价优的产品引入市场",
                "features": {
                    "keywords": [
                        "复星医药",
                        "带量采购",
                        "政策",
                        "质高价优",
                        "产品引入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-21",
                "original_text": "药品带量采购政策利好龙头企业",
                "features": {
                    "keywords": [
                        "药品",
                        "带量采购",
                        "政策",
                        "龙头企业",
                        "利好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}